Head to Head Review: CryoPort (NASDAQ:CYRX) & Armlogi (NASDAQ:BTOC)

Armlogi (NASDAQ:BTOC) and CryoPort (NASDAQ:CYRX) are both small-cap transportation companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, dividends, profitability and analyst recommendations.

Valuation & Earnings

This table compares Armlogi and CryoPort”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Armlogi	$190.41 million	0.06	-$15.35 million	($0.47)	-0.54
CryoPort	$176.18 million	4.70	$78.30 million	$1.35	12.16

CryoPort has lower revenue, but higher earnings than Armlogi. Armlogi is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Armlogi has a beta of 2.75, suggesting that its share price is 175% more volatile than the S&P 500. Comparatively, CryoPort has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Armlogi and CryoPort, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Armlogi	1	0	0	0	1.00
CryoPort	0	2	7	0	2.78

CryoPort has a consensus price target of $15.38, indicating a potential downside of 6.36%. Given CryoPort’s stronger consensus rating and higher possible upside, analysts plainly believe CryoPort is more favorable than Armlogi.

Profitability

This table compares Armlogi and CryoPort’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Armlogi	-10.70%	-104.33%	-13.30%
CryoPort	41.57%	-7.92%	-4.79%

Institutional and Insider Ownership

92.9% of CryoPort shares are owned by institutional investors. 66.8% of Armlogi shares are owned by insiders. Comparatively, 9.5% of CryoPort shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

CryoPort beats Armlogi on 11 of the 14 factors compared between the two stocks.

About Armlogi

Armlogi Holding Corp. is a warehousing and logistics service provider which offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment. Armlogi Holding Corp. is based in WALNUT, CA.

About CryoPort

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.